STOCKTON, CALIFORNIA / June 3, 2013 / Newswire/ — Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the signing of a letter of intent for a Joint Venture with California based Nanobeak Inc. to further develop NASA device to detect Volatile Organic Compounds (“VOC’s”) in breath tests that may be associated with infectious diseases, cancer, and other medical problems for screening purposes. The device currently in existence is about the size of a postage stamp and plugs into a cell phone to collect, process, and transmit the testing data to anywhere in the world.
Dr. Kevin Buckman, the CEO of Viratech states, “The System is based on a proven vapor phase sensor for known molecules present in the breath of individuals and fully integrated with a smart phone app. It is capable of being interfaced with disease experts in a global network.” Dr. Buckman has written a book called, “Breath Analysis,” and is also an expert on the need for Point of Care testing in third world countries and here domestically.
This technology, originally developed by NASA to identify biomarkers exhaled by astronauts in space flight, has now been developed for VOC screening to be both medically effective and economically affordable,” according to Dr. Buckman.
Viratech’s future goals include testing using the same handheld system for possible detection VOC’s associated with TB infections, cancer, and other diseases.
About Viratech Corp and Cancer.im
Viratech Corp. has created the first open source biotech research social network platform. The purpose of the platform is to make it possible for individuals or smaller companies to compete with larger companies in the race to patent new medicines or technology.
Viratech’s subsidiary, Cancer.im, Inc., owns and operates http://cancer.im, a social network resource site for cancer patients, survivors, advocates and volunteers. Cancer.im harnesses social collaboration utilities to develop what Viratech believes will become the first experience-based search engine powered by social collaboration.
Forward-Looking Statements:
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Contact: Dr. Kevin Buckman
Viratech, Corp.
http://viratech.org
Email Contact: info@viratech.org